This paper aimed to assess the technical efficiency of maize seed production and the major factors contributing on technical efficiency. Maize is the second most important staple crop in Nepal, but the average yield of maize is very low as compared to other countries having similar agro-climatic requirements. Inefficient use of resources had led to low yield in maize crop. The software Raosoft was used to determine the required sample size and total of 182 samples were selected using simple random technique in June, 2016. Stochastic production frontier model and Tobit model were used to derive the results. The average technical efficiency of maize seed production ranged from 0.25-0.92 with an average of 0.71which revealed the scope of increasing technical efficiency by 29 percent. The majority of the farmers (29.1%) were at higher technical efficiency level of 0.8-0.9 followed by 28.6 percent at 0.7-0.8 and 23.1 percent at 0.6-0.7. Age and schooling of household head, experience on maize seed production, area shared by maize crop and dummies variables such as livestock holding, source of seed and access to extension service had found significantly affecting on the technical efficiency level. For the least developed country like Nepal it would be better to use the available resources wisely and improvement of existing technologies would be more cost effective than that of discovering new technologies. The study recommended that the concerned organizations should focus on mixed agricultural farming system, access to better quality seed and provide technical knowledge which would help in improving technical efficiency.

Blood cancers, including leukemia, lymphoma, and myeloma, pose significant diagnostic challenges due to their diverse and complex nature. Detecting these cancers early and accurately is crucial for timely intervention and improved patient outcomes. This review explores current and emerging detection methods for human blood cancers, focusing on their principles, advantages, limitations, and potential clinical applications.

In recent years, the emergence of cancer drug resistance is one of the crucial tumor hallmarks which is supported by the level of genetic heterogeneity and complexities at cellular levels. Oxidative stress, immune evasion, metabolic reprogramming, overexpression of ABC transporters and stemness are among the several key contributing molecular and cellular response mechanisms. Topo-active drugs, e.g., doxorubicin and topotecan, are clinically active and are utilized extensively against a wide variety of human tumors and often results in the development of resistance and failure to therapy. Thus, there is an urgent need for an incremental and comprehensive understanding of mechanisms of cancer drug resistance specifically in the context of topo-active drugs. This review delves into the intricate mechanistic aspects of these intracellular and extracellular topo-active drug resistance mechanisms and explores use of potential combinatorial approaches by utilizing various topo-active drugs and inhibitors of pathways involved in drug resistance. We believe that this review will help guide basic scientists, pre-clinicians, clinicians, and policymakers toward holistic and interdisciplinary strategies that transcend resistance, renewing optimism in the ongoing battle against cancer.